Clinical trial
Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
NCT00004939 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 1996
- Completion date
- August 31, 1996
- Enrollment
- 34
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.